New combo therapy aims to bring color back to Vitiligo-Affected skin

This study tested whether adding an oral medication called apremilast to standard UVB light therapy helps restore skin color (repigmentation) in people with widespread, non-segmental vitiligo. For 24 weeks, all 80 participants received UVB light therapy twice a week. Those who responded well were then randomly assigned to continue with either apremilast or a placebo pill alongside the light therapy for another 24 weeks to see if the drug helped maintain or improve results.